The recent emphasis on tumor-selective metabolic pathways such as glutaminolysis, reductive carboxylation, and one-carbon metabolism places particularly a special focus on amino acid transporters for development of a new class of anticancer therapeutics [7,8,29,30]. The gene discussed is SLC38A7; the disease is neoplasm.